Federated Hermes, Inc. Aquestive Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.01 - $6.09 $2,100 - $6,364	-1,045 Reduced 42.67%	1,404 $5,000
Q4 2023 Jan 31, 2024	BUY	$1.29 - $2.47 $263 - $503	204 Added 9.09%	2,449 $4,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $2,379 - $5,590	2,245 New	2,245 $3,000
Q4 2020 Feb 12, 2021	SELL	$4.65 - $7.79 $269 - $451	-58 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.12 - $9.09 $238 - $527	58 New	58 $1,000

122

46.8M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.